News

Press Releases

Asuragen’s QuantideX® qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance for Monitoring Minimal Residual Disease in Chronic Myeloid Leukemia
Asuragen Launches the AmplideX® PCR/CE C9orf72 Kit for High-Resolution Genotyping of GC-rich Repeat Expansions Relevant to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Asuragen to Present Expansion of Next-Generation Sequencing Portfolio at American Association of Cancer Research Annual Meeting
Asuragen Names Colin Hill Senior Vice President of Commercial Operations
Asuragen Launches AmplideX® PCR/CE FMR1 Reporter*, a Fully Automated Software Solution for Accurate Sizing of the FMR1 CGG Repeat Region
Asuragen to Present at Upcoming 2015 Association for Molecular Pathology Annual Meeting in Austin, TX
Asuragen to Collaborate with Illumina on Companion Diagnostics Development
Asuragen Launches the QuantideX® NGS Pan Cancer Kit*, a Workflow Solution for Targeted Next-Generation Sequencing
Asuragen Announces Launch of Highly Sensitive CE-IVD BCR-ABL Assay at the European Hematology Association Annual Congress
Asuragen to present innovations in fragile X testing at upcoming American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

About

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close